❌

Normal view

Google Loses Final EU Antitrust Appeal

23 July 2026 at 20:46

Ryan Whitwam (PDF, Reddit):

Back in 2018, Google was handed a record-setting 4.34 billion-euro ($4.9 billion) fine in Europe for abusing its monopoly on Android. The company has spent the intervening years challenging that decision, but the continent’s highest court has put a stop to that. The Court of Justice of the European Union has affirmed the penalty, meaning Google is out of options.

[…]

The EU took issue with Google search and Chrome being the default options on Android. Even devices made by other companies, such as Samsung and Xiaomi, include Google apps as the default per the Android licensing agreement, giving Google an unfair advantage, according to European antitrust regulators. This is not to be confused with a 2.95 billion euro ($3.45 billion) fine against Google’s advertising monopoly issued by the European Union last year.

Arjun Kharpal:

In 2022, a lower EU court reduced the fine to the current 4.1 billion euros from 4.34 billion euros previously.

Google has argued that the Android operating system provides choice for users and supports developers and businesses across Europe.

Via John Gruber:

Google last year booked $132 billion in profit; this fine is about 3 percent of that..

[…]

There’s never a reason not to string the appeal process out, but it’s especially true when your profits are growing at an exceptional rate. By growing their profits around 5×, they’ve reduced the relative sting of this fine by 5×

Previously:

Voici l'épice du quotidien qui pourrait éloigner naturellement les souris de votre maison

16 July 2026 at 07:00
Les souris, ces petits rongeurs souvent indésirables, peuvent causer bien des soucis dans nos foyers. Mais saviez-vous qu'un simple ingrédient de cuisine pourrait les tenir à distance ? Découvrez comment la cannelle, avec son parfum envoûtant pour nous mais repoussant pour elles, peut devenir...

Ancient Romans Buried Secret Coin Hoards Across Europe and Never Retrieved Them—Now Archaeologists Finally Know Why

29 June 2026 at 18:17

A longstanding archaeological riddle involves the phenomenon of coin hoarding in the ancient Roman Empire—why were massive stashes of wealth often buried, and seemingly never retrieved?

Now scholars may finally be closer to knowing the answer, according to new findings published in the Journal of Ancient History and Archaeology. The research presents evidence drawn from several case studies that help to build the argument that many ancient Roman coin hoards were buried during periods of political upheaval, war, or other catastrophic periods of change, revealing that the recovery of these caches may not have always been practical, or even possible.

The Enigma of Roman Coin Hoards

For many centuries, treasure hunters, archaeologists, and others have made remarkable discoveries of buried hoards of Roman coins across Europe, North Africa, and the Middle East. Although the reasons why coin hoards were buried are sometimes fairly obvious, the real mystery for scholars throughout time has to do with why these troves—often representing significant amounts of wealth—remained unrecovered.

Roman coin hoard
An example of a Roman coin hoard uncovered near Llanvaches, Monmouthshire, in 2006 (Image Credit: Helen Hall/Wikimedia Commons/CC 2.0)

To answer this question, Babeş-Bolyai University researchers Adrian-Daniel Stan and Cristian Gǎzda leveraged one of the world’s largest databases on Roman coin hoards, and based on the data the pair reviewed, they suggest that these “forgotten fortunes” entombed within the earth can be viewed as the fingerprints left behind by some of the darkest periods in the Roman Empire.

 A Deeper Look at Roman Coin Hoards

Managed by the Ashmolean Museum and the University of Oxford, the Coin Hoards of the Roman Empire (CHRE) project is an extensive database comprised of more than 18,000 documented hoards.

With data on more than 7.5 million coins, the project’s database provided Gǎzda and Stan precisely the kind of information they needed to contrast discoveries of large troves of wealth buried throughout the ancient Roman world.

However, rather than focusing their study on why Romans hid their valuables in the first place, which has long remained the focus in past archaeological research, the team decided to try to better understand what prevented their reclamation.

Coin hoards were buried for a variety of reasons. Sometimes merchants would hide their wealth to conceal it from thieves or tax collectors. In other instances, treasure caches might have been buried for religious reasons, such as offerings or as part of rituals.

Roman Coin Hoard
A Roman coin hoard uncovered near Huntingdon, Cambridgeshire (Image Credit: Helen Fowler/CC 4.0)

In at least some instances, circumstantial clues help to illustrate that the hoards had been buried in what were intended as temporary hiding places, sometimes contained within ceramic vessels, bags or pouches made from leather, or within other kinds of containers.

Such discoveries have often been located below the flooring in houses or hearths—locations where it was likely expected that they would have been retrieved by their owners. When these hoards remained buried, it likely means something went wrong.

Aligning with this “catastrophic” interpretation, Gǎzda and Stan relied on spatial and chronological analyses of the CHRE database, which revealed clusters of unrecovered hoard discoveries that frequently coincided with major upheavals that included wars, invasions, and natural disasters known in the historic record.

The Battle of the Teutoburg Forest

One example the research team focused on occurred in A.D. 9, where a trio of Roman legions was obliterated by Germanic tribes. This event, known as the Battle of the Teutoburg Forest, aligned with several coin hoards found around a battlefield area at Kalkriese, as well as the nearby Roman fort of Haltern; a pattern implying that soldiers and civilians had likely buried their valuables, and never had opportunities to recover them.

Battle of Teutoburg Forest
Martin Disteli’s 1830s lithograph depicting the Battle of Teutoburg Forest, in which Varus is depicted falling on his sword (Public Domain).

Similar patterns were observed in Britain, where concentrations of hoards matched with periods of tribal warfare, as well as the beginning of the Roman conquest in A.D. 43, and other instances. Further south, another concentration appears around Mount Vesuvius just after the devastating eruption that occurred in A.D. 79, which buried Pompeii beneath a blanket of volcanic ash.

Still other examples of hoard “clusters” emerge from the data in areas that include the Danube frontier during the Dacian Wars, and amid invasions that were prevalent during the crisis period the Roman Empire underwent during the third century.

Overall, the patterns reveal that these unrecovered hoards provide a unique archaeological record of upheaval and insecurity in the ancient world that helps to complement and verify written history and other archaeological research.

A Tale of Two Phenomena

Significantly, Gǎzda and Stan observe that there are two distinctive phenomena that emerge from these failures to recover buried treasure. One involved the practical concern of protecting one’s wealth, and avoidance of taxation, while the other involved more tragic circumstances like death, displacement due to battle, invasion, natural disaster, or other dramatic periods of change.

Through this lens of understanding, the buried coin hoards become more than just intriguing discoveries of lost valuables from ancient times: they offer a unique record of some of history’s most unpredictable forces, and a deeper perspective on the ways humans coped with insecurity while trying to survive and cope with changes in the ancient world.

The team’s study, “Why Did They Not Recover the Hoards? Insecurity in the Roman Empire,” appeared in the Journal of Ancient History and Archaeology.

Micah Hanks is the Editor-in-Chief and Co-Founder of The Debrief. A longtime reporter on science, defense, and technology with a focus on space and astronomy, he can be reached at micah@thedebrief.org. Follow him on X @MicahHanks, and at micahhanks.com.

A “Magical” Ancient Curse Artifact Turned Up in an Unexpected Location—and in the Wrong Language

24 June 2026 at 14:19

A “cursed” ancient Roman tablet, intended to invoke divine and demonic wrath upon one’s enemies, has been deciphered by researchers at Heidelberg University in Germany.

The magical lead tablet, originally discovered by Dutch archaeologists in the Netherlands, was crafted in the second century AD. Strangely, it is written in ancient Greek, although in an Egyptian style, rather than the Latin that would be expected for what was then a Roman province of Lower Germania.

Today, the excavation site within the city of Heerlen in the southeast of the Netherlands, near the German border, is home to the country’s largest ancient Roman ruins.

Curse Tablets

The object is not entirely unique, as it belongs to a category of curse tablets called katadesmoi in Greek and defixiones in Latin. The Greeks and Romans believed that cold, heavy iron was especially useful in binding supernatural entities, making it the go-to material for crafting such objects.

As this artifact’s material was both cold and heavy, it reminded ancient people of the bleak underworld. Additionally, lead is also easy to work with in practice, as it is both inexpensive and easy to inscribe.

These small tablets were typically inscribed with curses and then buried, with the intention of bringing misfortune upon rivals in matters of sport, law, or love.

At the time the tablet was created, Heerlen was a Roman military settlement known as Coriovallum. Dutch archaeologists unearthed the 9.3-by-4.8-centimeter katadesmos from a pit beneath the former town square.

Deciphering an Ancient Curse

Researchers at the University of Heidelberg’s Institute for Papyrology used reflectance transformation imaging, a technique that combines photographs taken under different lighting conditions to enhance subtle surface details. Their analysis revealed three distinct types of characters within the inscription.

The combination of Egyptian-style invocations of deities and demons written in ancient Greek is highly unusual for a region where Latin was the dominant written language. Also notable are three symbols known as “Characteres”—magical symbols believed to facilitate communication with supernatural entities—along with two male and two female names.

Dr. Rodney Ast, Academic Director of the Institute for Papyrology, suggests that these four individuals were either the targets of the curse or those on whose behalf it was created. However, Dr. Julia Lougovaya, a research associate at the institute, notes that the male names are Latin while the female names are Greek, a distinction that may hold additional significance.

“It cannot be ruled out that one of the two women was the author of the inscription and had brought the supposed ability to communicate with divine powers through such curses with her from Roman Egypt,” said Dr. Lougovaya.

Ancient Magical Practices

Magic played an important role in Egyptian society, where rituals aimed at healing and protection formed a visible part of religious life, while malicious spells were typically practiced more discreetly.

“In the early centuries A.D., Near Eastern, Egyptian, Jewish, and sometimes even Christian traditions increasingly merged and spread throughout the entire Roman Empire of that time – a development that the discovery from Heerlen impressively underscores,” explained Prof. Joachim Quack, Director of the Institute for Egyptology at Heidelberg University.

A forthcoming scholarly publication will provide the full transcription of the inscription and details of the analysis. The tablet is also scheduled to go on display at a museum in Heerlen in the future.

Ryan Whalen covers science and technology for The Debrief. He holds an MA in History and a Master of Library and Information Science with a certificate in Data Science. He can be contacted at ryan@thedebrief.org, and follow him on Twitter @mdntwvlf.

New Study Suggests Microplastics Could Aggravate Fatty Liver Disease

17 June 2026 at 23:15

Microplastics: Unseen Threats to Liver Health Revealed Through Cutting-Edge Spatial Transcriptomics

In recent years, microplastics have emerged as pervasive environmental contaminants, infiltrating virtually every corner of the globe. These minuscule plastic particles, derived from the breakdown of larger plastic debris, have invaded air, water, and soil, exposing humans to continuous contact via inhalation, ingestion, and dermal absorption. Despite the ubiquity of microplastics, understanding their direct impact on biological systems has remained a formidable challenge within the scientific community. A groundbreaking study by researchers at the University of Oklahoma, recently published in the journal Science Advances, delves into this critical area by examining how microplastics particularly affect liver health under dietary stress conditions.

Tae Gyu Oh, Ph.D., an assistant professor of oncology science at the University of Oklahoma College of Medicine and lead author of the study, highlights the pressing concern: “Exposure to microplastics is inevitable. Their presence in human tissues has been confirmed across multiple studies. However, we wanted to investigate how microplastic exposure interacts with a high-fat, high-cholesterol diet, known to independently induce liver damage.” The study offers compelling evidence that the combination of a typical Western diet and microplastic exposure exacerbates liver injury, potentially accelerating the progression of metabolic liver diseases.

Central to the study is the focus on polyethylene, the most prevalent plastic polymer globally, commonly found in everyday items such as plastic bags and milk containers. The research team administered polyethylene microplastics to mice over eight weeks, with one cohort receiving a standard diet and another subjected to a diet mimicking metabolic dysfunction-associated steatohepatitis (MASH). This severe form of fatty liver disease is characterized by inflammation and liver cell damage, often culminating in cirrhosis and liver failure if untreated.

The findings were striking: mice consuming the high-fat diet alongside microplastic exposure exhibited blood markers indicating liver injury more than twice as elevated as those on a standard diet experiencing similar exposure. This synergistic effect underscores the intricate interplay between environmental pollutants and diet-induced metabolic stressors, intensifying hepatic damage beyond what each factor causes independently.

To unravel the molecular and cellular underpinnings of this phenomenon, the research employed an array of sophisticated analytical techniques, culminating in the use of spatial transcriptomics. Unlike conventional bulk transcriptomic approaches, which average gene expression across millions of cells and can obscure localized responses, spatial transcriptomics enables researchers to map transcriptional activity within intact tissue sections at near single-cell resolution. This technique revealed precise “hot spots” of inflammation and tissue injury within the liver, a breakthrough insight unattainable by earlier methodologies.

Analysis of gene regulatory networks through spatial transcriptomics indicated a pivotal role for PPAR-alpha (peroxisome proliferator-activated receptor-alpha), a nuclear receptor that orchestrates fat metabolism and energy homeostasis in liver cells. PPAR-alpha appears to engage in cross-talk with Anxa2, a gene implicated in tissue repair and membrane dynamics. The altered activity of this axis in microplastic-exposed livers suggests that microplastics may disrupt the liver’s natural defense and regenerative processes, impairing its capacity to recover from metabolic insults.

This discovery has profound implications for understanding the mechanistic pathways by which environmental contaminants like microplastics contribute to liver pathology. The perturbation of PPAR-alpha and Anxa2 signaling potentially links microplastic exposure with the dysregulation of lipid metabolism and compromised repair, exacerbating the severity of conditions such as nonalcoholic fatty liver disease (NAFLD) and MASH.

While these findings were generated in a murine model, they establish an essential framework that informs potential human health risks. Given the parallels between murine and human liver physiology, it is plausible that microplastic exposure combined with high-fat diets could similarly predispose humans to aggravated liver damage. However, the researchers caution that further studies are necessary to confirm this translation and to elucidate the long-term implications for populations worldwide.

Dr. Oh emphasizes the broader relevance of this research: “Microplastics are now inextricably linked to daily life, yet their biological impact is only beginning to be understood. Through advanced spatial transcriptomic mapping, we have visualized the precise loci of hepatic damage induced by microplastics, revealing a novel environmental dimension to liver disease pathogenesis.” This nuanced comprehension paves the way for future investigations targeting environmental and dietary risk factors in liver health.

Moreover, these insights open avenues for therapeutic targeting. Modulating the PPAR-alpha-Anxa2 pathway could become a strategy to mitigate microplastic-induced liver injury or fortify the liver’s resilience against environmental toxins. Understanding such molecular crosstalk also facilitates improved diagnostic markers sensitive to environmental damage, allowing for earlier intervention in vulnerable populations.

This pioneering study exemplifies the intersection of environmental health, genomics, and hepatology, demonstrating how innovative technologies can elucidate complex biological interactions. It underscores the urgent need to address microplastic pollution not only as an ecological crisis but as a public health priority, particularly in societies where high-fat diets are prevalent.

As humanity grapples with escalating plastic waste and its fragmentary descent into invisible pollutants, research such as this serves as a clarion call for comprehensive strategies. Reducing plastic production, enhancing waste management, and fostering healthier dietary practices collectively form the cornerstone of mitigating hidden dangers to liver health and overall well-being.

The University of Oklahoma study, titled “Spatial Transcriptome Mapping Identifies Ppara-Anxa2 Crosstalk in Microplastic-Induced Hepatotoxicity,” stands as a seminal contribution offering unprecedented mechanistic clarity. Through employing spatial transcriptomics, the researchers have achieved a level of resolution that redefines how environmental toxicology and metabolic disease research can coalesce to confront emergent health threats posed by our plastic-saturated environment.

Subject of Research: Animals
Article Title: Spatial transcriptome mapping identifies Ppara-Anxa2 cross-talk in microplastic-induced hepatotoxicity
News Publication Date: 17-Jun-2026
Web References: https://doi.org/10.1126/sciadv.aec8681
References: Oh, T.G., Jung, W., Joshi, A.D., et al. Spatial Transcriptome Mapping Identifies Ppara-Anxa2 Crosstalk in Microplastic-Induced Hepatotoxicity. Science Advances, 2026.
Image Credits: University of Oklahoma
Keywords: Microplastics, Liver Disease, Fatty Liver Disease, Polyethylene, High-Fat Diets, Spatial Transcriptomics, PPAR-alpha, Anxa2, Hepatotoxicity, Environmental Health, Metabolic Dysfunction, Inflammation

Effectiveness of Prone Positioning in Infants with Acute Bronchiolitis: New Insights

17 June 2026 at 15:54

A recent clinical investigation into the impact of prone positioning on infants suffering from moderate to severe bronchiolitis has brought new insights into pediatric respiratory care. Bronchiolitis, an acute infection of the lower respiratory tract commonly caused by respiratory syncytial virus (RSV), presents a significant healthcare challenge worldwide, particularly among infants. The study specifically targeted infants receiving high-flow nasal cannula (HFNC) therapy, a common supportive treatment designed to improve oxygenation and reduce respiratory effort. Despite its widespread use, the efficacy of adjunctive positioning techniques like prone positioning in this population has remained uncertain until now.

The trial explored whether placing infants in the prone position—lying on their stomachs—could influence clinical outcomes, specifically by reducing the escalation of care. Escalation of care represents clinical deterioration requiring increased respiratory support, such as moving from HFNC to mechanical ventilation or intensive care admission. The physiological rationale behind prone positioning lies in its known benefits in improving ventilation-perfusion matching, enhancing lung mechanics, and optimizing secretion clearance. These effects have been well-documented in adult acute respiratory distress syndrome (ARDS) management, yet pediatric evidence remains limited.

In the conducted study, infants with moderate to severe bronchiolitis under HFNC support were randomized to receive either prone positioning or continue with standard positioning protocols. Researchers meticulously monitored clinical outcomes, including respiratory parameters, oxygenation indices, and the need for escalating respiratory support over the treatment course. The cohort was carefully selected to include infants representing a range of disease severities, thereby ensuring the findings would be broadly applicable to clinical practice.

Contrary to expectations driven by adult data and mechanistic theories, the results revealed no statistically significant reduction in care escalation rates associated with prone positioning in this infant population. The observed odds ratio exhibited a wide 95% confidence interval, indicating variability and uncertainty around the estimate. This statistical phenomenon suggests that while the study failed to demonstrate definitive benefit, it did not conclusively exclude the possibility that certain subgroups might still derive clinical advantage from this intervention.

The ambiguity exposed by the confidence intervals underscores the complex interplay of factors influencing respiratory mechanics and disease progression in bronchiolitis. The heterogeneity of this disease, rooted in diverse viral etiologies and varying host immune responses, may attenuate the effects of positional changes on lung function. Moreover, compliance with prone positioning protocols can be particularly challenging in infants, owing to safety concerns and caregiver adherence, potentially diluting any therapeutic effect.

Physiologically, the application of high-flow nasal cannula therapy delivers heated and humidified oxygen at flow rates sufficient to generate a mild positive end-expiratory pressure (PEEP), which helps maintain alveolar patency. Prone positioning theoretically complements this by redistributing ventilation, reducing dorsal lung atelectasis, and improving secretion mobilization. However, the dynamic respiratory mechanics of infants, coupled with the distinct pathophysiology of bronchiolitis characterized primarily by airway inflammation and mucus plugging, may limit the translation of these theoretical benefits into clinical outcomes.

In reviewing the methodological aspects, the study was conducted with rigorous adherence to randomized controlled trial protocols. Blinding was implemented where feasible, and standardized clinical criteria dictated escalation of care, thereby minimizing potential biases. The statistical power and sample size calculations accounted for anticipated effect sizes based on previous smaller studies, yet the results accentuated the need for larger, multicentric trials to verify findings and identify responsive patient subsets.

The absence of clear benefit does not diminish the value of prone positioning as a component of critical care but rather refines its role within the therapeutic armamentarium for bronchiolitis. Clinical decisions must integrate a nuanced understanding of individual patient factors, balancing potential physiological advantages against logistical and safety considerations. Additionally, continued research investigating adjunctive therapies, including pharmacologic agents and alternative respiratory support modalities, remains imperative to improve outcomes for this vulnerable population.

This investigation is particularly timely given the ongoing global burden of bronchiolitis and the frequent hospitalization of infants due to severe respiratory distress. Optimizing non-invasive interventions like HFNC and positioning could significantly impact healthcare resource utilization and patient morbidity if proven effective. Until then, prudent clinical judgment guided by evolving evidence must steer treatment approaches.

Future studies should employ advanced imaging and respiratory monitoring techniques such as electrical impedance tomography and lung ultrasound to elucidate the mechanistic effects of prone positioning on infant lung ventilation and perfusion patterns. Stratification by viral etiology, age, and baseline respiratory status could also uncover subpopulations more amenable to positional interventions. Furthermore, integrating caregiver education and safety protocols will enhance feasibility and adherence, potentially amplifying clinical benefits.

In summary, the recent multicenter randomized trial encompassing infants with moderate to severe bronchiolitis on high-flow nasal cannula support indicates that prone positioning does not significantly reduce the risk of escalation of care. Nevertheless, the wide confidence intervals highlight that this evidence is not conclusive, and further meticulously designed research is warranted. Advancing the understanding of respiratory mechanics and therapeutic positioning strategies in bronchiolitis remains a critical priority in pediatric medicine.

Corresponding author Dr. Florent Baudin emphasizes the necessity for ongoing critical appraisal and clinical trials to refine pediatric respiratory care practices. The study’s findings, presented at the International Congress of the European Society of Paediatric and Neonatal Intensive Care, contribute valuable data to the pediatric critical care community. Engaging clinicians, researchers, and healthcare providers in collaborative efforts will be essential to translate these insights into improved outcomes for infants affected by this common yet severe respiratory condition.


Subject of Research:
Prone positioning effectiveness in infants with moderate to severe bronchiolitis receiving high-flow nasal cannula therapy.

Article Title:
Not provided.

News Publication Date:
Not provided.

Web References:
Not provided.

References:
Not provided.

Image Credits:
Not provided.

Keywords:
Bronchiolitis, infants, prone positioning, high-flow nasal cannula, respiratory disorders, pediatric intensive care, respiratory support, lung mechanics, clinical research, acute infections, observational studies, medical treatments.

New Insights into PPARγ Regulation and Metabolic Disorders

17 June 2026 at 12:25

Metabolic disorders such as obesity and type 2 diabetes mellitus (T2DM) have escalated into a global health crisis, posing unprecedented challenges for medical science and public health policy alike. Both conditions disrupt fundamental biological processes, culminating in severe systemic complications and heightened mortality risks worldwide. At the molecular level, peroxisome proliferator-activated receptor gamma (PPARγ) emerges as a pivotal regulator, overseeing lipid metabolism, insulin sensitivity, and adipocyte differentiation. This critical role underscores PPARγ as a prime therapeutic target in the ongoing battle against metabolic syndromes.

The classical pharmacological approach to modulating PPARγ activity involves thiazolidinediones (TZDs), compounds that exert potent insulin-sensitizing effects by binding primarily to the receptor’s ligand-binding domain (LBD). While effective, these agents have repeatedly encountered clinical hurdles due to significant adverse effects, including undesirable weight gain, fluid retention, and exacerbated cardiovascular risk profiles. Consequently, the quest for safer, more selective PPARγ modulation strategies has intensified, driving innovative research toward dissecting the receptor’s structure-function relationship and regulatory mechanisms with extraordinary precision.

Recent advances have unveiled a complex, multi-layered regulatory network governing PPARγ activity. Among these, the modulation of post-translational modifications—specifically the phosphorylation of serine 273 (Ser273)—has attracted substantial attention. Selective PPARγ modulators (SPPARMs) that target this phosphorylation event strategically preserve the metabolic benefits of PPARγ activation without engaging the full spectrum of activity triggered by TZDs. This nuanced receptor engagement mitigates off-target effects and may revolutionize treatment paradigms in metabolic disease management.

A groundbreaking integration of the long non-coding RNA (lncRNA) Snhg9 into the PPARγ regulatory landscape marks a new frontier in understanding gene expression control in metabolic homeostasis. The recently characterized Snhg9-CCAR2-SIRT1-PPARγ axis exemplifies a sophisticated RNA-mediated regulatory mechanism influencing PPARγ function. This regulatory cascade suggests that lncRNAs may serve as potent modulators of metabolism, potentially enabling RNA-based therapeutic strategies that transcend classical small-molecule pharmacology.

Beyond ligand-dependent regulation, the DNA-binding domain (DBD) of PPARγ has emerged as a promising, yet underexplored, target for gene-selective modulation. This evolving paradigm challenges the current LBD-centric therapeutic design by emphasizing the possibility of fine-tuning receptor activity at the level of gene-specific transcriptional control. Manipulation of the DBD may enable precision targeting of specific metabolic pathways, offering an unprecedented level of therapeutic specificity and efficacy.

The intersection of molecular biology and pharmacology in PPARγ research underscores the critical need for comprehensive structural and functional analyses. High-resolution crystallographic studies have shed light on conformational dynamics within PPARγ domains, illuminating how subtle structural modifications dictate receptor activation states and downstream target gene expression. These insights inform the rational design of modulators capable of exploiting unique allosteric sites with therapeutic benefits.

An intricate balance exists between PPARγ phosphorylation states and the recruitment of coregulators such as CCAR2 and SIRT1, modulators that orchestrate epigenetic and transcriptional machinery. SIRT1, a NAD+-dependent deacetylase, interacts intricately within this axis to regulate metabolic gene programs by modulating PPARγ acetylation and activity. This interplay suggests potential synergies between metabolic control mechanisms and cellular energy sensing pathways, which could be harnessed therapeutically.

The discovery of lncRNAs as key regulatory nodes in metabolic control systems elevates the importance of non-coding genomic elements. Snhg9, in particular, has been implicated in modulating PPARγ’s transcriptional repertoire through its interactions with cofactors, altering chromatin accessibility and the receptor’s response to endogenous ligands. Such findings delineate a novel class of epigenetic regulators, spotlighting RNA as a powerful switch in metabolic gene networks.

Clinical translation of these mechanistic insights depends heavily on the development of SPPARMs that not only modulate Ser273 phosphorylation but also integrate with lncRNA-mediated pathways. Such compounds hold the promise of robust insulin sensitization while bypassing the adverse events that have plagued TZDs. The future of metabolic therapeutics likely hinges on these dual-targeting molecules that couple protein conformation control with RNA-regulatory axis modulation.

Emerging technologies in RNA therapeutics offer an extraordinary toolkit for manipulating lncRNA functions in vivo. Antisense oligonucleotides, RNA interference, and CRISPR-Cas systems could potentially modulate the expression or function of Snhg9, thereby indirectly regulating PPARγ activity. These approaches raise hopeful prospects for personalized metabolic treatments grounded in gene regulation rather than merely receptor agonism.

PPARγ’s pivotal position in adipocyte differentiation links it intimately with lipid homeostasis and energy storage, fundamental processes derailed in obesity and T2DM. Understanding how selective modulation of PPARγ influences adipogenesis at the transcriptional level could redefine therapeutic goals from symptomatic control to addressing root causes of metabolic dysregulation. This shift would be transformative for millions affected worldwide.

The newly recognized hierarchy within the PPARγ regulatory framework beckons a strategic roadmap toward next-generation therapies. This roadmap involves integrated targeting of receptor phosphorylation, lncRNA interaction networks, cofactor recruitment, and domain-specific modulation, all underpinned by cutting-edge molecular insights. The multi-dimensional approach promises enhanced efficacy with minimized side effects, offering a viable path beyond the limitations of current therapeutic agents.

Exciting possibilities also arise from exploring how SPPARMs interface with other nuclear receptors and metabolic pathways, which could reveal combinatory or synergistic effects beneficial in polygenic diseases. Such multidrug or multifunctional agents could revolutionize treatment regimens by addressing the complex etiology of metabolic disorders more holistically.

In summary, recent advances position PPARγ at the nexus of a sophisticated, multi-layered regulatory system with immense therapeutic potential. The dual focus on selective receptor modulation and lncRNA-mediated regulation heralds a paradigm shift in metabolic disease treatment. As research continues to unravel these complex mechanisms, the prospect for innovative, effective, and safer therapies to combat obesity and T2DM grows more tangible than ever before.


Subject of Research: Regulation of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in metabolic disorders including obesity and type 2 diabetes mellitus, focusing on selective modulation strategies and the role of long non-coding RNAs.

Article Title: Novel perspectives on PPARγ regulation: from SPPARMs to the emerging role of lncRNAs in metabolic disorders.

Article References:
Qin, H., Wang, Y., Yang, Y. et al. Novel perspectives on PPARγ regulation: from SPPARMs to the emerging role of lncRNAs in metabolic disorders. Int J Obes (2026). https://doi.org/10.1038/s41366-026-02128-w

Image Credits: AI Generated

DOI: 17 June 2026

Google Chrome's Next Update Will Mark the End of Popular Ad Blockers

By: BeauHD
15 June 2026 at 22:00
Google is removing Chrome's last remaining workarounds for Manifest V2 extensions, effectively ending support for legacy ad blockers such as the original uBlock Origin. 9to5Google reports: CyberNews points out a Chromium commit that removes support for the "kExtensionManifestV2Disabled" flag, which is referred to as "dead code" seeing as Chrome no longer supports Manifest V2 extensions. This removal acts as the final stop for many Manifest V2-based ad blocker extensions that were still in use today -- the flag was effectively a loophole to continue using these extensions. A Googler on the commit explains: "MV2 extensions are no longer allowed in any supported version of Chrome, and we are removing support for them and the associated functionality. We won't be able to provide / maintain this functionality indefinitely due to the complexity and tech debt, as well as the security risks it entails (we've actually found a number of bugs that are specific to MV2 lately). Of course, other browsers can continue supporting these if they so desire." This will also impact other Chromium-based browsers, though the comment notes that "other browsers can continue supporting these if they so desire." Neowin points out that Microsoft Edge and Opera are likely to follow suit. Chrome 150, set to be released later this month, will remove this flag, while other leftover bits of Manifest V2 will be removed in the v151 release.

Read more of this story at Slashdot.

Google Chrome is closing the loopholes that let old ad blockers keep working

15 June 2026 at 19:06
An image showing the Chrome logo surrounded by yellow circles

Google Chrome version 150 and 151, expected in late June and July, respectively, will cut off support for the last remaining workarounds for running older ad blockers, 9to5Google reports. Google phased out support for ad-blocking extensions built for Manifest V2, like uBlock Origin, in 2024. At that point, most Chrome users either switched to newer Manifest V3 ad blockers like uBlock Origin Lite or switched to a different browser.

Google is now removing the final bits of code referencing its previous Manifest V2 extensions platform, so only ad blockers that work on the Manifest V3 platform will work in Chrome version 151 onward.

Google d …

Read the full story at The Verge.

❌